Eli Lilly: We Haven't Reached Its Peak Yet (Rating Upgrade) [Seeking Alpha]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: Seeking Alpha
LLY's medium-term growth is anchored by obesity drugs Mounjaro and Zepbound, with Foundayo and the Kelonia acquisition as near-term catalysts. Consensus expects robust EPS growth (+43% in FY26), but risks include GLP-1 therapy persistence and postmarketing requirements for Foundayo. Supply chain investments and pipeline assets like retatrutide reinforce LLY's long-term moat, though capex may pressure near-term margins. bortnikau/iStock via Getty Images Since my last Eli Lilly and Company ( LLY analysis , the stock has declined by 12.5% in price. At the time, I issued a Hold rating after trimming my position by 50% for a 39% return as a short-term
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- Eli Lilly (LLY): 3 Reasons We Love This Stock [Yahoo! Finance]Yahoo! Finance
- Eli Lilly expands genetic medicine capabilities with Kelonia Therapeutics acquisition [Yahoo! Finance]Yahoo! Finance
- Will Eli Lilly's New GLP-1 Pill Get the Stock Get Back to a $1 Trillion Valuation? [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Will Eli Lilly's New GLP-1 Pill Get the Stock Get Back to a $1 Trillion Valuation? [Yahoo! Finance]Yahoo! Finance
- Lilly to acquire Kelonia Therapeutics to advance in vivo CAR-T cell therapies [TheStreet.com]TheStreet.com
LLY
Earnings
- 2/4/26 - Beat
LLY
Sec Filings
- 4/20/26 - Form SCHEDULE
- 3/26/26 - Form SCHEDULE
- 3/20/26 - Form DEFA14A
- LLY's page on the SEC website